Skip to main content
Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
130.67
-0.78 (-0.60%)
At close: Apr 28, 2026, 4:00 PM EDT
129.40
-1.27 (-0.97%)
After-hours: Apr 28, 2026, 6:05 PM EDT

Inhibrx Biosciences Revenue

In the year 2025, Inhibrx Biosciences had annual revenue of $1.30M with 550.00% growth.

Revenue (ttm)
$1.30M
Revenue Growth
+550.00%
P/S Ratio
1,474.07
Revenue / Employee
$11,818
Employees
110
Market Cap
1.91B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.30M1.10M550.00%
Dec 31, 2024200.00K-1.60M-88.89%
Dec 31, 20231.80M485.00K36.88%
Dec 31, 20221.32M-5.92M-81.81%
Dec 31, 20217.23M-5.66M-43.89%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Galapagos NV 1.31B
Harmony Biosciences Holdings 868.45M
Vericel 276.26M
Stoke Therapeutics 184.42M
Syndax Pharmaceuticals 172.35M
Recursion Pharmaceuticals 74.68M
Mesoblast 65.38M
Taysha Gene Therapies 9.77M
Revenue Rankings

INBX News

More News